Profitability:
Adjusted profitability improved, with Q1 2026 adjusted EBITDA higher than the prior year and full‑year 2026 adjusted EBITDA guidance raised. Non‑GAAP earnings improved even as GAAP results were affected by non‑cash goodwill impairments.
Healthy Cash Flow:
Operating cash flow was positive in Q1 2026, and trailing twelve‑month unlevered free cash flow was cited at roughly $49.9 million. Cash generation remained positive through 2025, providing support during the top‑line transition.
Cost & Operational Efficiency:
Expense discipline and restructuring helped expand margins and deliver results at or above the high end of guidance in late 2025 and Q1 2026. Management is emphasizing efficiency while continuing targeted investments in product, integrations, and AI features.
.jpg)
